Similarly, high levels of miR-150 reduced GAB1 expression, subsequently downregulated phosphorylated ERK1/2 and inhibited EMT, while low levels of miR-150 were associated with worse outcomes in HCC patients. Here, MAPK3 is linked to hepatocellular carcinoma.